Hydroxychloroquine Sulphate Market

Hydroxychloroquine sulfate was listed in the United States in 1955 and used in malaria, rheumatoid arthritis and lupus erythematosus. The variety has been approved in more than 70 countries such as Canada, France, Germany, Australia, China, Japan, etc.

Hydroxychloroquine sulfate, initially an anti malarial drug, was found to have mild immunosuppressive and immunomodulatory effects in clinical practice.

Hydroxychloroquine Sulphate Market contains market size and forecasts of Hydroxychloroquine Sulphate in global, including the following market information:

Global Hydroxychloroquine Sulphate Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Hydroxychloroquine Sulphate Market Sales, 2017-2022, 2023-2028, (K Pcs)

Global top five Hydroxychloroquine Sulphate companies in 2021 (%)

The global Hydroxychloroquine Sulphate market was valued at 904.9 million in 2021 and is projected to reach US$ 1026.5 million by 2028, at a CAGR of 1.8% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

100mg Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Hydroxychloroquine Sulphate include Sanofi, Novartis, Shanghai Zhongxisanwei, Teva, Zydus Cadila, Mylan, Apotex, Advanz Pharma and Sun Pharma, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Hydroxychloroquine Sulphate manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Hydroxychloroquine Sulphate Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)

Global Hydroxychloroquine Sulphate Market Segment Percentages, by Type, 2021 (%)

100mg

200mg

Others

Global Hydroxychloroquine Sulphate Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)

Global Hydroxychloroquine Sulphate Market Segment Percentages, by Application, 2021 (%)

Lupus Erythematosus

Rheumatoid Arthritis

Others

Global Hydroxychloroquine Sulphate Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)

Global Hydroxychloroquine Sulphate Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Hydroxychloroquine Sulphate revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Hydroxychloroquine Sulphate revenues share in global market, 2021 (%)

Key companies Hydroxychloroquine Sulphate sales in global market, 2017-2022 (Estimated), (K Pcs)

Key companies Hydroxychloroquine Sulphate sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Sanofi

Novartis

Shanghai Zhongxisanwei

Teva

Zydus Cadila

Mylan

Apotex

Advanz Pharma

Sun Pharma

Kyung Poong

Ipca Laboratories

Hanlim Pharmaceutical

Bristol Laboratories